vs
Side-by-side financial comparison of GAIA, INC (GAIA) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
GAIA, INC is the larger business by last-quarter revenue ($25.5M vs $20.4M, roughly 1.3× Sight Sciences, Inc.). GAIA, INC runs the higher net margin — -0.3% vs -20.4%, a 20.1% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs 5.8%). GAIA, INC produced more free cash flow last quarter ($76.0K vs $-2.0M). Over the past eight quarters, GAIA, INC's revenue compounded faster (9.4% CAGR vs 2.9%).
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
GAIA vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $20.4M |
| Net Profit | $-75.0K | $-4.2M |
| Gross Margin | 87.6% | 87.3% |
| Operating Margin | -2.6% | -18.0% |
| Net Margin | -0.3% | -20.4% |
| Revenue YoY | 5.8% | 6.9% |
| Net Profit YoY | 91.7% | 64.9% |
| EPS (diluted) | $-0.02 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $20.4M | ||
| Q3 25 | $25.0M | $19.9M | ||
| Q2 25 | $24.6M | $19.6M | ||
| Q1 25 | $23.8M | $17.5M | ||
| Q4 24 | $24.1M | $19.1M | ||
| Q3 24 | $22.0M | $20.2M | ||
| Q2 24 | $21.9M | $21.4M | ||
| Q1 24 | $21.3M | $19.3M |
| Q4 25 | $-75.0K | $-4.2M | ||
| Q3 25 | $-1.2M | $-8.2M | ||
| Q2 25 | $-2.0M | $-11.9M | ||
| Q1 25 | $-1.2M | $-14.2M | ||
| Q4 24 | $-907.0K | $-11.8M | ||
| Q3 24 | $-1.2M | $-11.1M | ||
| Q2 24 | $-2.2M | $-12.3M | ||
| Q1 24 | $-971.0K | $-16.3M |
| Q4 25 | 87.6% | 87.3% | ||
| Q3 25 | 86.4% | 86.4% | ||
| Q2 25 | 86.7% | 84.8% | ||
| Q1 25 | 87.7% | 86.2% | ||
| Q4 24 | 88.2% | 86.8% | ||
| Q3 24 | 86.1% | 83.9% | ||
| Q2 24 | 84.5% | 85.8% | ||
| Q1 24 | 85.3% | 85.5% |
| Q4 25 | -2.6% | -18.0% | ||
| Q3 25 | -5.0% | -39.7% | ||
| Q2 25 | -8.9% | -59.6% | ||
| Q1 25 | -4.3% | -79.2% | ||
| Q4 24 | -7.1% | -62.5% | ||
| Q3 24 | -5.3% | -55.7% | ||
| Q2 24 | -9.1% | -59.2% | ||
| Q1 24 | -4.0% | -76.4% |
| Q4 25 | -0.3% | -20.4% | ||
| Q3 25 | -4.6% | -41.0% | ||
| Q2 25 | -8.3% | -61.0% | ||
| Q1 25 | -5.1% | -80.8% | ||
| Q4 24 | -3.8% | -62.1% | ||
| Q3 24 | -5.4% | -54.9% | ||
| Q2 24 | -9.9% | -57.7% | ||
| Q1 24 | -4.6% | -84.4% |
| Q4 25 | $-0.02 | $-0.07 | ||
| Q3 25 | $-0.05 | $-0.16 | ||
| Q2 25 | $-0.07 | $-0.23 | ||
| Q1 25 | $-0.04 | $-0.28 | ||
| Q4 24 | $-0.03 | $-0.23 | ||
| Q3 24 | $-0.05 | $-0.22 | ||
| Q2 24 | $-0.09 | $-0.25 | ||
| Q1 24 | $-0.05 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.5M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $87.9M | $63.9M |
| Total Assets | $154.6M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.5M | $92.0M | ||
| Q3 25 | $14.2M | $92.4M | ||
| Q2 25 | $13.9M | $101.5M | ||
| Q1 25 | $13.1M | $108.8M | ||
| Q4 24 | $5.9M | $120.4M | ||
| Q3 24 | $4.4M | $118.6M | ||
| Q2 24 | $5.5M | $118.2M | ||
| Q1 24 | $8.6M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $87.9M | $63.9M | ||
| Q3 25 | $86.3M | $64.3M | ||
| Q2 25 | $85.7M | $70.0M | ||
| Q1 25 | $87.0M | $77.6M | ||
| Q4 24 | $80.7M | $87.5M | ||
| Q3 24 | $81.2M | $95.0M | ||
| Q2 24 | $82.1M | $101.6M | ||
| Q1 24 | $84.8M | $109.2M |
| Q4 25 | $154.6M | $115.3M | ||
| Q3 25 | $151.1M | $116.3M | ||
| Q2 25 | $147.0M | $122.0M | ||
| Q1 25 | $148.5M | $129.7M | ||
| Q4 24 | $141.2M | $142.8M | ||
| Q3 24 | $139.6M | $143.6M | ||
| Q2 24 | $142.1M | $149.7M | ||
| Q1 24 | $133.8M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-1.8M |
| Free Cash FlowOCF − Capex | $76.0K | $-2.0M |
| FCF MarginFCF / Revenue | 0.3% | -9.7% |
| Capex IntensityCapex / Revenue | 6.6% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $-1.8M | ||
| Q3 25 | $326.0K | $-8.7M | ||
| Q2 25 | $2.3M | $-7.5M | ||
| Q1 25 | $1.3M | $-11.6M | ||
| Q4 24 | $2.7M | $-3.5M | ||
| Q3 24 | $409.0K | $362.0K | ||
| Q2 24 | $-2.1M | $-9.5M | ||
| Q1 24 | $5.9M | $-9.8M |
| Q4 25 | $76.0K | $-2.0M | ||
| Q3 25 | $-1.6M | $-8.9M | ||
| Q2 25 | $880.0K | $-7.8M | ||
| Q1 25 | $268.0K | — | ||
| Q4 24 | $1.6M | $-3.6M | ||
| Q3 24 | $-952.0K | $311.0K | ||
| Q2 24 | $-3.5M | $-9.5M | ||
| Q1 24 | $4.9M | $-9.9M |
| Q4 25 | 0.3% | -9.7% | ||
| Q3 25 | -6.4% | -44.7% | ||
| Q2 25 | 3.6% | -39.6% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 6.5% | -18.9% | ||
| Q3 24 | -4.3% | 1.5% | ||
| Q2 24 | -16.1% | -44.7% | ||
| Q1 24 | 22.8% | -51.4% |
| Q4 25 | 6.6% | 0.8% | ||
| Q3 25 | 7.7% | 0.9% | ||
| Q2 25 | 5.7% | 1.1% | ||
| Q1 25 | 4.3% | 0.0% | ||
| Q4 24 | 4.6% | 0.7% | ||
| Q3 24 | 6.2% | 0.3% | ||
| Q2 24 | 6.6% | 0.4% | ||
| Q1 24 | 5.0% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
